P19338 (NUCL_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 139.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nucleolin Alternative name(s): Protein C23 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 710 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Nucleolin is the major nucleolar protein of growing eukaryotic cells. It is found associated with intranucleolar chromatin and pre-ribosomal particles. It induces chromatin decondensation by binding to histone H1. It is thought to play a role in pre-rRNA transcription and ribosome assembly. May play a role in the process of transcriptional elongation. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Ref.8 |
| Subunit structure | Identified in a mRNP granule complex, at least composed of ACTB, ACTN4, DHX9, ERG, HNRNPA1, HNRNPA2B1, HNRNPAB, HNRNPD, HNRNPL, HNRNPR, HNRNPU, HSPA1, HSPA8, IGF2BP1, ILF2, ILF3, NCBP1, NCL, PABPC1, PABPC4, PABPN1, RPLP0, RPS3, RPS3A, RPS4X, RPS8, RPS9, SYNCRIP, TROVE2, YBX1 and untranslated mRNAs. Interacts with APTX and NSUN2. Component of the SWAP complex that consists of NPM1, NCL/nucleolin, PARP1 and SWAP70. Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin. Interacts (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains) with TERT; the interaction is important for nucleolar localization of TERT. Interacts with ERBB4. Interacts with GZF1; this interaction is important for nucleolar localization of GZF1. Ref.10 Ref.11 Ref.17 Ref.19 Ref.29 |
| Subcellular location | Nucleus › nucleolus. Cytoplasm. Note: Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Ref.9 Ref.17 Ref.20 Ref.29 |
| Post-translational modification | Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group By similarity. |
| Sequence similarities | Contains 4 RRM (RNA recognition motif) domains. |
| Sequence caution | The sequence BAC03738.1 differs from that shown. Reason: Unlikely isoform. Aberrant splice sites. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Polymorphism |
| Domain | Repeat |
| Ligand | DNA-binding RNA-binding |
| PTM | Acetylation Methylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | angiogenesis Inferred from direct assay. Source: UniProtKB |
| Cellular component | cell cortex Inferred from direct assay. Source: UniProtKB nucleolusInferred from direct assay. Source: UniProtKB ribonucleoprotein complexInferred from direct assay Ref.20. Source: UniProtKB |
| Molecular function | RNA binding Inferred from direct assay Ref.7. Source: UniProtKB nucleotide bindingInferred from electronic annotation. Source: InterPro protein C-terminus bindingInferred from physical interaction. Source: UniProtKB telomeric DNA bindingInferred from direct assay Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ARRB1 | P49407 | 3 | EBI-346967,EBI-743313 | |
| ARRB2 | P32121 | 3 | EBI-346967,EBI-714559 | |
| MDM2 | Q00987 | 2 | EBI-346967,EBI-389668 | |
| MYH9 | P35579 | 3 | EBI-346967,EBI-350338 | |
| PA2G4 | Q9UQ80 | 2 | EBI-346967,EBI-924893 | |
| PAX8 | Q06710 | 2 | EBI-346967,EBI-2683132 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.5 | ||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 710 | 709 | Nucleolin | PRO_0000081691 | |||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||
| Repeat | 58 – 65 | 8 | 1 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 75 – 82 | 8 | 2 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 83 – 90 | 8 | 3 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 91 – 98 | 8 | 4 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 99 – 104 | 6 | 5; truncated | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 105 – 112 | 8 | 6 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 120 – 127 | 8 | 7 | ||||||||||||||||||||||||||||||||||||||||
| Repeat | 128 – 135 | 8 | 8 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 307 – 383 | 77 | RRM 1 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 393 – 466 | 74 | RRM 2 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 486 – 560 | 75 | RRM 3 | ||||||||||||||||||||||||||||||||||||||||
| Domain | 572 – 647 | 76 | RRM 4 | ||||||||||||||||||||||||||||||||||||||||
| Region | 58 – 135 | 78 | 8 X 8 AA tandem repeats of X-T-P-X-K-K-X-X | ||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 143 – 171 | 29 | Asp/Glu-rich (acidic) | ||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 185 – 209 | 25 | Asp/Glu-rich (acidic) | ||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 234 – 271 | 38 | Asp/Glu-rich (acidic) | ||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 649 – 698 | 50 | Arg/Gly/Phe-rich | ||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 9 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 28 | 1 | Phosphoserine Ref.12 Ref.14 Ref.27 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 34 | 1 | Phosphoserine Ref.14 Ref.27 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 41 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 42 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 67 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.18 Ref.21 Ref.22 Ref.23 Ref.24 Ref.25 Ref.27 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 69 | 1 | Phosphothreonine Ref.18 Ref.22 Ref.23 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 76 | 1 | Phosphothreonine Ref.15 Ref.18 Ref.22 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 99 | 1 | Phosphothreonine Ref.13 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 102 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 105 | 1 | Phosphothreonine Ref.13 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 106 | 1 | Phosphothreonine Ref.22 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 113 | 1 | Phosphothreonine Ref.22 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 116 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 121 | 1 | Phosphothreonine Ref.14 Ref.15 Ref.18 Ref.22 Ref.24 Ref.25 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 124 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 132 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 145 | 1 | Phosphoserine Ref.12 Ref.14 Ref.16 Ref.24 Ref.25 Ref.26 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 153 | 1 | Phosphoserine Ref.12 Ref.14 Ref.16 Ref.24 Ref.25 Ref.26 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 184 | 1 | Phosphoserine Ref.16 Ref.21 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 206 | 1 | Phosphoserine Ref.16 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 214 | 1 | Phosphothreonine Ref.21 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 318 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 333 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 367 | 1 | Phosphothreonine Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 377 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 398 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 403 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 460 | 1 | Phosphoserine Ref.27 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 513 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 563 | 1 | Phosphoserine Ref.13 Ref.14 Ref.18 Ref.21 Ref.22 Ref.23 Ref.24 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 572 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 577 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 580 | 1 | Phosphoserine Ref.15 Ref.22 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 619 | 1 | Phosphoserine Ref.15 Ref.24 Ref.25 Ref.27 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 646 | 1 | N6-acetyllysine Ref.28 | ||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 68 | 1 | P → L. Corresponds to variant rs11542691 [ dbSNP | Ensembl ]. | VAR_046353 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 122 | 1 | P → L. Corresponds to variant rs11542687 [ dbSNP | Ensembl ]. | VAR_046354 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 174 | 1 | A → V. Corresponds to variant rs11542689 [ dbSNP | Ensembl ]. | VAR_046355 | |||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 549 | 1 | E → G in BAC03738. Ref.3 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 623 – 626 | 4 | Missing in AAA59954. Ref.2 | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 625 – 627 | 3 | Missing Ref.1 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 486 – 492 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 499 – 505 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 510 – 513 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 518 – 520 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 524 – 529 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 533 – 542 | 10 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 544 – 548 | 5 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 551 – 557 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 565 – 568 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 572 – 577 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 585 – 590 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 596 – 602 | 7 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 604 – 606 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 608 – 616 | 9 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 620 – 630 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 641 – 644 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 650 – 652 | 3 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and sequencing of the human nucleolin cDNA." Srivastava M., Fleming P.J., Pollard H.B., Burns A.L. FEBS Lett. 250:99-105(1989) [PubMed: 2737305] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Retina. |
| [2] | "Genomic organization and chromosomal localization of the human nucleolin gene." Srivastava M., McBride O.W., Fleming P.J., Pollard H.B., Burns A.L. J. Biol. Chem. 265:14922-14931(1990) [PubMed: 2394707] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Hair follicle dermal papilla. |
| [4] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937." Krantz S., Salazar R., Brandt R., Kellermann J., Lottspeich F. Biochim. Biophys. Acta 1266:109-112(1995) [PubMed: 7718615] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-7; 349-362 AND 610-624. Tissue: Lymphoma. |
| [6] | "Major cell surface-located protein substrates of an ecto-protein kinase are homologs of known nuclear proteins." Jordan P., Heid H., Kinzel V., Kubler D. Biochemistry 33:14696-14706(1994) [PubMed: 7993898] [Abstract] Cited for: PROTEIN SEQUENCE OF 231-236; 349-362; 399-403; 458-461 AND 649-653. |
| [7] | "Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n." Ishikawa F., Matunis M.J., Dreyfuss G., Cech T.R. Mol. Cell. Biol. 13:4301-4310(1993) [PubMed: 8321232] [Abstract] Cited for: PROTEIN SEQUENCE OF 458-474, NUCLEOTIDE-BINDING. Tissue: Cervix carcinoma. |
| [8] | "A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription." Parada C.A., Roeder R.G. EMBO J. 18:3688-3701(1999) [PubMed: 10393184] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POLYMERASE II; SUPT5H AND CDK9. |
| [9] | "Functional proteomic analysis of human nucleolus." Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C., Greco A., Hochstrasser D.F., Diaz J.-J. Mol. Biol. Cell 13:4100-4109(2002) [PubMed: 12429849] [Abstract] Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Aprataxin, a novel protein that protects against genotoxic stress." Gueven N., Becherel O.J., Kijas A.W., Chen P., Howe O., Rudolph J.H., Gatti R., Date H., Onodera O., Taucher-Scholz G., Lavin M.F. Hum. Mol. Genet. 13:1081-1093(2004) [PubMed: 15044383] [Abstract] Cited for: INTERACTION WITH APTX. |
| [11] | "Nucleolin interacts with telomerase." Khurts S., Masutomi K., Delgermaa L., Arai K., Oishi N., Mizuno H., Hayashi N., Hahn W.C., Murakami S. J. Biol. Chem. 279:51508-51515(2004) [PubMed: 15371412] [Abstract] Cited for: INTERACTION WITH TERT. |
| [12] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-67; SER-145 AND SER-153, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-99; THR-105 AND SER-563, MASS SPECTROMETRY. Tissue: Colon adenocarcinoma. |
| [14] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-34; SER-41; SER-42; SER-67; THR-121; SER-145; SER-153 AND SER-563, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-76; THR-121; SER-580 AND SER-619, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145; SER-153; SER-184 AND SER-206, MASS SPECTROMETRY. Tissue: Prostate cancer. |
| [17] | "Nucleolin modulates the subcellular localization of GDNF-inducible zinc finger protein 1 and its roles in transcription and cell proliferation." Dambara A., Morinaga T., Fukuda N., Yamakawa Y., Kato T., Enomoto A., Asai N., Murakumo Y., Matsuo S., Takahashi M. Exp. Cell Res. 313:3755-3766(2007) [PubMed: 17674968] [Abstract] Cited for: INTERACTION WITH GZF1, SUBCELLULAR LOCATION. |
| [18] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69; THR-76; THR-121 AND SER-563, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Aurora-B regulates RNA methyltransferase NSUN2." Sakita-Suto S., Kanda A., Suzuki F., Sato S., Takata T., Tatsuka M. Mol. Biol. Cell 18:1107-1117(2007) [PubMed: 17215513] [Abstract] Cited for: INTERACTION WITH NSUN2. |
| [20] | "Molecular composition of IMP1 ribonucleoprotein granules." Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R., Johnsen A.H., Christiansen J., Nielsen F.C. Mol. Cell. Proteomics 6:798-811(2007) [PubMed: 17289661] [Abstract] Cited for: IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION. |
| [21] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-184; THR-214 AND SER-563, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [22] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69; THR-76; THR-106; THR-113; THR-121; SER-563 AND SER-580, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [23] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69 AND SER-563, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [24] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69; THR-76; THR-121; SER-145; SER-153; SER-184; SER-206; THR-214; THR-367; SER-563 AND SER-619, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-121; SER-145; SER-153 AND SER-619, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [26] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145 AND SER-153, MASS SPECTROMETRY. |
| [27] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-34; SER-67; SER-460 AND SER-619, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [28] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-102; LYS-116; LYS-124; LYS-132; LYS-318; LYS-333; LYS-377; LYS-398; LYS-403; LYS-513; LYS-572; LYS-577 AND LYS-646, MASS SPECTROMETRY. |
| [29] | "Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways." Gilmore-Hebert M., Ramabhadran R., Stern D.F. Mol. Cancer Res. 8:1388-1398(2010) [PubMed: 20858735] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH ERBB4, SUBCELLULAR LOCATION. |
| [30] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [31] | "Solution structure of the RRM_1 domain of NCL protein." RIKEN structural genomics initiative (RSGI) Submitted (JUN-2006) to the PDB data bank Cited for: STRUCTURE BY NMR OF 478-566. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M60858 Genomic DNA. Translation: AAA59954.1. AK091742 mRNA. Translation: BAC03738.1. Sequence problems. AC017104 Genomic DNA. Translation: AAY24247.1. | ||||||||||||||||||||||||
| IPI | IPI00604620. | ||||||||||||||||||||||||
| PIR | A35804. S53728. | ||||||||||||||||||||||||
| RefSeq | NP_005372.2. NM_005381.2. | ||||||||||||||||||||||||
| UniGene | Hs.79110. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P19338. | ||||||||||||||||||||||||
| SMR | P19338. Positions 300-648. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-89N. | ||||||||||||||||||||||||
| IntAct | P19338. 42 interactions. | ||||||||||||||||||||||||
| MINT | MINT-4999081. | ||||||||||||||||||||||||
| STRING | P19338. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P19338. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 90110781. | ||||||||||||||||||||||||
2D gel databases | |||||||||||||||||||||||||
| SWISS-2DPAGE | P19338. | ||||||||||||||||||||||||
| Aarhus/Ghent-2DPAGE | 1210. NEPHGE. | ||||||||||||||||||||||||
| DOSAC-COBS-2DPAGE | P19338. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | P19338. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000322723; ENSP00000318195; ENSG00000115053. | ||||||||||||||||||||||||
| GeneID | 4691. | ||||||||||||||||||||||||
| KEGG | hsa:4691. | ||||||||||||||||||||||||
| NMPDR | fig|9606.3.peg.19498. | ||||||||||||||||||||||||
| UCSC | uc002vru.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 4691. | ||||||||||||||||||||||||
| GeneCards | GC02M232318. | ||||||||||||||||||||||||
| HGNC | HGNC:7667. NCL. | ||||||||||||||||||||||||
| HPA | CAB004210. HPA023981. | ||||||||||||||||||||||||
| MIM | 164035. gene. | ||||||||||||||||||||||||
| neXtProt | NX_P19338. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG19742. | ||||||||||||||||||||||||
| GeneTree | ENSGT00550000074656. | ||||||||||||||||||||||||
| HOGENOM | HBG756718. | ||||||||||||||||||||||||
| HOVERGEN | HBG002295. | ||||||||||||||||||||||||
| InParanoid | P19338. | ||||||||||||||||||||||||
| OMA | GTEPTTA. | ||||||||||||||||||||||||
| OrthoDB | EOG45MN5J. | ||||||||||||||||||||||||
| PhylomeDB | P19338. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | aurora_b_pathway. Aurora B signaling. telomerasepathway. Regulation of Telomerase. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| Bgee | P19338. | ||||||||||||||||||||||||
| CleanEx | HS_NCL. | ||||||||||||||||||||||||
| Genevestigator | P19338. | ||||||||||||||||||||||||
| GermOnline | ENSG00000115053. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR012677. Nucleotide-bd_a/b_plait. IPR000504. RRM_dom. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:3.30.70.330. a_b_plait_nuc_bd. 4 hits. | ||||||||||||||||||||||||
| KO | K11294. | ||||||||||||||||||||||||
| Pfam | PF00076. RRM_1. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00360. RRM. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50102. RRM. 4 hits. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| NextBio | 18090. | ||||||||||||||||||||||||
| PMAP-CutDB | P19338. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | NUCL_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P19338 Secondary accession number(s): Q53SK1 Q9UDG1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with